PMC:7068164 / 14553-15786 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"176","span":{"begin":966,"end":976},"obj":"Species"},{"id":"177","span":{"begin":246,"end":256},"obj":"Disease"},{"id":"178","span":{"begin":301,"end":310},"obj":"Disease"},{"id":"179","span":{"begin":622,"end":627},"obj":"Disease"}],"attributes":[{"id":"A176","pred":"tao:has_database_id","subj":"176","obj":"Tax:2697049"},{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"MESH:D007239"},{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"MESH:D007239"},{"id":"A179","pred":"tao:has_database_id","subj":"179","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"With increasing numbers of cases in Europe, data from surveillance and investigations in the region can build on the evidence from countries in Asia experiencing more widespread transmission particularly on disease spectrum and the proportion of infections with severe outcome [22]. Understanding the infection-severity is critical to help plan for the impact on the healthcare system and the wider population. Serological studies are vital to understand the proportion of cases who are asymptomatic. Hospital-based surveillance could help estimate the incidence of severe cases and identify risk factors for severity and death. Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose. In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2. This approach will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T50","span":{"begin":246,"end":256},"obj":"Disease"},{"id":"T51","span":{"begin":301,"end":310},"obj":"Disease"},{"id":"T52","span":{"begin":693,"end":702},"obj":"Disease"},{"id":"T53","span":{"begin":920,"end":929},"obj":"Disease"},{"id":"T54","span":{"begin":966,"end":974},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"With increasing numbers of cases in Europe, data from surveillance and investigations in the region can build on the evidence from countries in Asia experiencing more widespread transmission particularly on disease spectrum and the proportion of infections with severe outcome [22]. Understanding the infection-severity is critical to help plan for the impact on the healthcare system and the wider population. Serological studies are vital to understand the proportion of cases who are asymptomatic. Hospital-based surveillance could help estimate the incidence of severe cases and identify risk factors for severity and death. Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose. In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2. This approach will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T98","span":{"begin":278,"end":280},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T99","span":{"begin":779,"end":780},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T100","span":{"begin":1093,"end":1098},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"With increasing numbers of cases in Europe, data from surveillance and investigations in the region can build on the evidence from countries in Asia experiencing more widespread transmission particularly on disease spectrum and the proportion of infections with severe outcome [22]. Understanding the infection-severity is critical to help plan for the impact on the healthcare system and the wider population. Serological studies are vital to understand the proportion of cases who are asymptomatic. Hospital-based surveillance could help estimate the incidence of severe cases and identify risk factors for severity and death. Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose. In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2. This approach will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread."}

{"project":"LitCovid-sentences","denotations":[{"id":"T132","span":{"begin":0,"end":282},"obj":"Sentence"},{"id":"T133","span":{"begin":283,"end":410},"obj":"Sentence"},{"id":"T134","span":{"begin":411,"end":500},"obj":"Sentence"},{"id":"T135","span":{"begin":501,"end":628},"obj":"Sentence"},{"id":"T136","span":{"begin":629,"end":765},"obj":"Sentence"},{"id":"T137","span":{"begin":766,"end":977},"obj":"Sentence"},{"id":"T138","span":{"begin":978,"end":1233},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"With increasing numbers of cases in Europe, data from surveillance and investigations in the region can build on the evidence from countries in Asia experiencing more widespread transmission particularly on disease spectrum and the proportion of infections with severe outcome [22]. Understanding the infection-severity is critical to help plan for the impact on the healthcare system and the wider population. Serological studies are vital to understand the proportion of cases who are asymptomatic. Hospital-based surveillance could help estimate the incidence of severe cases and identify risk factors for severity and death. Established hospital surveillance systems that are in place for influenza and other diseases in Europe may be expanded for this purpose. In addition, a number of countries in Europe are adapting and, in some cases, already using existing sentinel primary care based surveillance systems for influenza to detect community transmission of SARS-CoV-2. This approach will be used globally to help identify evidence of widespread community transmission and, should the virus spread and containment no longer be deemed feasible, to monitor intensity of disease transmission, trends and its geographical spread."}